Exalted is spot on - Stage 2 combination animal testing with Eurofins has started or is imminent with our EUA application to follow. Additionally if successful; it is the opinion of FDA consultants Camargo Pharmaceutical Services (‘Camargo’) that IHL-675A will be a candidate for FDA Emergency Use Authorisation resulting from the COVID-19 Pandemic. The designation of Emergency Use Authorisation could facilitate an expedited investigational new drug (IND) meeting with the FDA, which could facilitate the commencement of inhuman clinical trials in which IHL would test IHL-675A in patients with COVID-19.
IHL Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
